Eupraxia Pharmaceuticals is hitting the investor conference circuit, showcasing its proprietary Diffusphere™ drug delivery technology at several key events...

Supernus Pharmaceuticals is set to announce its second-quarter 2025 financial results on August 5th, offering a critical glimpse into...

Sutro Biopharma’s collaboration with the FDA to develop reference materials for antibody-drug conjugates (ADCs) marks a significant step toward...

Seres Therapeutics will host a conference call on August 6th to discuss second-quarter 2025 financial results and provide business...

Seres Therapeutics is undergoing a significant leadership transition as it navigates a challenging financial landscape and seeks to capitalize...

Telix Pharmaceuticals reported strong second-quarter 2025 results, with unaudited group revenue reaching approximately $204 million, a 63% year-over-year increase....

Life Biosciences Forges Singapore Alliance to Advance Epigenetic Reprogramming for Age-Related Diseases Life Biosciences has signed a memorandum of...

Scancell Holdings PLC has announced compelling Phase 2 data from its SCOPE trial, evaluating SCIB1/ISCIb1+ Immunobody® DNA active immunotherapies...

Sanofi’s acquisition of ViceBio for an upfront payment of $1.15 billion, plus potential milestones, signals a strategic move to...

Biogen is showcasing its commitment to Alzheimer’s disease research with a robust data presentation at the 2025 Alzheimer’s Association...